Andrew Plumridge

Andrew Plumridge is currently the SVP of BD&L CDMO at Vectura Group. Prior to this role, Andrew held positions such as Director of Business Management at Catalent Pharma Solutions, Vice President of JPS Commercial Services at Juniper Pharma Services, and various titles at Molecular Profiles. Before their industry experience, Andrew worked as a Senior Research Scientist at Novozymes Biopharma UK Ltd and held research positions at the University of Nottingham and Mologic Ltd. Andrew Plumridge holds a PhD from the University of Nottingham and a BSc in Biology from the University of Hull.